Date published: 2026-5-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

CT47B1 Activators

Activators that modulate the CT47B1 protein operate through a range of biochemical mechanisms, each contributing to the enhancement of the protein's functional activity within the cellular environment. For instance, certain activators interact with signaling pathways that involve second messengers such as cyclic AMP, leading to phosphorylation events that can enhance protein activity. These phosphorylation events are often mediated by protein kinases, which can alter the activity, localization, or interactions of the protein, culminating in the increased activity of CT47B1. Moreover, changes in intracellular calcium levels, induced by some activators, can trigger a cascade of calcium-dependent signaling processes that ultimately result in the activation of CT47B1. Additionally, activators that modulate the chromatin state, such as those influencing histone acetylation or DNA methylation, play a role in the regulation of CT47B1 expression by altering the accessibility of the gene to the transcriptional machinery, thereby affecting its activity.

Moreover, several activators may impact CT47B1 activity by influencing the broader regulatory networks within the cell. For instance, signaling molecules that inhibit specific kinase pathways or disrupt growth factor signaling can indirectly lead to the activation of CT47B1 by altering the balance of intracellular signaling cascades. Through these intricate networks, activators can modulate the activity of CT47B1 by participating in the fine-tuning of protein-protein interactions and the regulation of gene expression. This holistic approach to activation reflects the complexity of cellular systems, where the modulation of one component can reverberate through multiple pathways, leading to the activation of CT47B1.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Elevates cAMP levels, which could enhance CT47B1 activity by cAMP-dependent protein kinase A.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Increases intracellular calcium, potentially enhancing CT47B1 activity through calcium signaling.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Inhibits DNA methyltransferases, possibly leading to demethylation and activation of CT47B1.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Histone deacetylase inhibitor, may increase CT47B1 expression by promoting a more open chromatin.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methyltransferase inhibitor, could activate CT47B1 expression through DNA demethylation.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

TGF-β receptor inhibitor, might enhance CT47B1 activity by altering TGF-β pathway signaling.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor, could indirectly activate CT47B1 by modulating downstream signaling pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor, might enhance CT47B1 activity by affecting the MAPK/ERK pathway.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Disrupts calcium homeostasis, potentially enhancing CT47B1 activity through stress response.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Regulates gene expression via retinoic acid receptors, could upregulate CT47B1 activity.